Key points are not available for this paper at this time.
Caffeine therapy for apnea of prematurity improves the rate of survival without neurodevelopmental disability at 18 to 21 months in infants with very low birth weight. (ClinicalTrials.gov number, NCT00182312 ClinicalTrials.gov.).
Schmidt et al. (Wed,) studied this question.